Ivabradine for Treatment of Coronary Artery Disease: From Last Chance Resort to Mainstem of a Reasoned Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-6182|13|1|4-9

ISSN： 1871-5257

Source： Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol.13, Iss.1, 2015-01, pp. : 4-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Coronary artery disease management with ivabradine in clinical practice

By Pinto Fausto J.  

European Heart Journal Supplements, Vol. 13, Iss. 1, 2011-09 ,pp. : 25-29

Oxford University Press

Access to resources Recommend Favorite

Reconsidering the Treatment of Patients with Coronary Artery Disease: A New Possibility from CAMELOT

By Taddei Stefano  

High Blood Pressure & Cardiovascular Prevention, Vol. 12, Iss. 2, 2005-01 ,pp. : 67-72

Adis International

Access to resources Recommend Favorite

Treatment effects of renin-angiotensin system inhibitor and calcium channel blocker in patients with coronary artery narrowing (from the Japanese Coronary Artery Disease Study)

By Fujita Masatoshi  

Heart and Vessels, Vol. 25, Iss. 6, 2010-11 ,pp. : 453-459

Springer Publishing Company

Access to resources Recommend Favorite

Interventional treatment and outcome in elderly patients with stable coronary artery disease: Results from the German ALKK registry

By Rittger H.   Hochadel M.   Behrens S.   Hauptmann K.E.   Zahn R.   Mudra H.   Brachmann J.   Zeymer U.  

Herz, Vol. 39, Iss. 2, 2014-03 ,pp. : 212-218

Springer Publishing Company

Access to resources Recommend Favorite

Effectiveness of sirolimus-eluting stent for treatment of left main coronary artery disease

By Arampatzis C.A.   Lemos P.A.   Tanabe K.  

ACC Current Journal Review, Vol. 12, Iss. 6, 2003-11 ,pp. : 48-49

Elsevier

Access to resources Recommend Favorite